Douglas Halverson

1.5k total citations
18 papers, 1.2k citations indexed

About

Douglas Halverson is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Douglas Halverson has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Douglas Halverson's work include Ferrocene Chemistry and Applications (5 papers), Cancer Mechanisms and Therapy (5 papers) and Mechanisms of cancer metastasis (5 papers). Douglas Halverson is often cited by papers focused on Ferrocene Chemistry and Applications (5 papers), Cancer Mechanisms and Therapy (5 papers) and Mechanisms of cancer metastasis (5 papers). Douglas Halverson collaborates with scholars based in United States, India and Canada. Douglas Halverson's co-authors include Patricia S. Steeg, Diane Palmieri, Taoufik Ouatas, Massimiliano Salerno, Rosalba Salcedo, Michael Dambach, Douglas Powell, Joost J. Oppenheim, James H. Resau and Ken Wasserman and has published in prestigious journals such as Blood, Molecular and Cellular Biology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Douglas Halverson

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Halverson United States 14 720 531 256 208 197 18 1.2k
Steven A. Enkemann United States 18 783 1.1× 414 0.8× 121 0.5× 185 0.9× 110 0.6× 31 1.3k
Yoko Ueno Japan 13 901 1.3× 377 0.7× 217 0.8× 125 0.6× 150 0.8× 19 1.4k
Iwan Beuvink Switzerland 11 1.1k 1.6× 840 1.6× 204 0.8× 169 0.8× 132 0.7× 13 1.7k
Harvey H. Hensley United States 21 628 0.9× 305 0.6× 211 0.8× 105 0.5× 174 0.9× 41 1.2k
Motoyoshi Tanaka Japan 22 919 1.3× 361 0.7× 244 1.0× 159 0.8× 68 0.3× 49 1.5k
Erika von Euw United States 18 893 1.2× 757 1.4× 269 1.1× 353 1.7× 105 0.5× 30 1.6k
Yan Degenhardt United States 16 1.1k 1.5× 663 1.2× 190 0.7× 99 0.5× 92 0.5× 23 1.6k
Grant Wickman Canada 13 764 1.1× 374 0.7× 291 1.1× 188 0.9× 67 0.3× 21 1.4k
Hermine Schlagbauer‐Wadl Austria 16 1.2k 1.7× 820 1.5× 98 0.4× 299 1.4× 85 0.4× 19 1.8k
Woondong Jeong United States 9 974 1.4× 732 1.4× 164 0.6× 126 0.6× 119 0.6× 23 1.5k

Countries citing papers authored by Douglas Halverson

Since Specialization
Citations

This map shows the geographic impact of Douglas Halverson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Halverson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Halverson more than expected).

Fields of papers citing papers by Douglas Halverson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Halverson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Halverson. The network helps show where Douglas Halverson may publish in the future.

Co-authorship network of co-authors of Douglas Halverson

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Halverson. A scholar is included among the top collaborators of Douglas Halverson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Halverson. Douglas Halverson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Palmieri, Diane, Julie L. Bronder, Jeanne M. Herring, et al.. (2007). Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain. Cancer Research. 67(9). 4190–4198. 267 indexed citations
2.
Palmieri, Diane, Christine E. Horak, Jong‐Heun Lee, Douglas Halverson, & Patricia S. Steeg. (2006). Translational approaches using metastasis suppressor genes. Journal of Bioenergetics and Biomembranes. 38(3-4). 151–161. 43 indexed citations
3.
Palmieri, Diane, Douglas Halverson, Taoufik Ouatas, et al.. (2005). Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor–Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 97(9). 632–642. 99 indexed citations
5.
Steeg, Patricia S., Taoufik Ouatas, Douglas Halverson, Diane Palmieri, & Massimiliano Salerno. (2003). Metastasis Suppressor Genes: Basic Biology and Potential Clinical Use. Clinical Breast Cancer. 4(1). 51–62. 111 indexed citations
6.
Ouatas, Taoufik, Douglas Halverson, & Patricia S. Steeg. (2003). Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.. PubMed. 9(10 Pt 1). 3763–72. 66 indexed citations
7.
Khaled, Annette R., Julie A. Hixon, Douglas Halverson, et al.. (2002). Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax. Blood. 100(1). 217–223. 48 indexed citations
8.
Salcedo, Rosalba, James H. Resau, Douglas Halverson, et al.. (2000). Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cells. The FASEB Journal. 14(13). 2055–2064. 217 indexed citations
9.
Halverson, Douglas, et al.. (2000). A novel member of the Swi6p family of fission yeast chromo domain-containing proteins associates with the centromere in vivo and affects chromosome segregation. Molecular Genetics and Genomics. 264(4). 492–505. 18 indexed citations
10.
Le, Yingying, Jinyue Hu, Wanghua Gong, et al.. (2000). Expression of functional formyl peptide receptors by human astrocytoma cell lines. Journal of Neuroimmunology. 111(1-2). 102–108. 80 indexed citations
11.
Aguilera, Andrés, et al.. (2000). Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death and Differentiation. 7(6). 574–586. 104 indexed citations
12.
Halverson, Douglas, James Resau, Robert J. Fisher, et al.. (1999). A MOUSE FIBROBLAST LINE CYCLES BETWEEN MONOLAYER AND SPHEROID FORMS, REGULATES MET AND HGF EXPRESSION, AND RELEASES AN ATTACHMENT AND GROWTH‐PROMOTING SUBSTANCE. Cell Biology International. 23(4). 257–274. 3 indexed citations
13.
Halverson, Douglas, et al.. (1997). Characterization of human N8 protein. Oncogene. 15(21). 2577–2588. 23 indexed citations
14.
Kaplan, David R., et al.. (1993). Signal transduction in c-met mediated motogenesis.. PubMed. 65. 107–30. 45 indexed citations
15.
Halverson, Douglas, W.S. Modi, Michael Dean, et al.. (1990). An oncogenic chromosome 8-9 gene fusion isolated following transfection of human ovarian carcinoma cell line DNA.. PubMed. 5(7). 1085–9. 4 indexed citations
16.
Chmurny, Gwendolyn N., Bruce D. Hilton, Douglas Halverson, et al.. (1988). An NMR blood test for cancer: a critical assessment. NMR in Biomedicine. 1(3). 136–150. 37 indexed citations
17.
Halverson, Douglas, Haleem J. Issaq, Gary M. Muschik, et al.. (1988). A Comparison of High Performance Gel Permeation Chromatography and Nuclear Magnetic Resonance Spectroscopy in the Analysis of Plasma from Normal Subjects and Cancer Patients. Journal of Liquid Chromatography. 11(3). 647–664. 8 indexed citations
18.
Sen, Arup, Douglas Halverson, Ulf R. Rapp, & George J. Todaro. (1979). Sarcoma virus-specific phosphoproteins are packaged in “rescued” type C virions. Virology. 92(1). 245–251. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026